SYSTEM AND METHOD FOR CURRENT STEERING NEUROSTIMULATION

• US 20160206883A1
• Filed: 01/19/2015
• Published: 07/21/2016
• Est. Priority Date: 01/19/2015
• Status: Abandoned Application

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Bornzin, Gene A., Venkatesan, Lalit, Nabutovsky, Yelena, Shah, Riddhi, Bharmi, Rupinder, Karst, Edward, Kent, Alexander, Min, Xiaoyi
• Application Number:
  US14/599,960
• Publication Number:
  US 20160206883A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36178 Burst or pulse train parameters
• CPC Class Codes: A61N 1/36182 Direction of the electrical field, e.g. with sleeve around stimulating electrode

Abstract

A system and method for current steering a neurostimulation signal is provided. The system and method provide a lead coupled to an implantable pulse generator (IPG). The lead may include a plurality of electrodes. The lead may be configured to be implanted at a target position proximate to tissue of interest. The system and method program the IPG to deliver at least a first pulse train to a first electrode and a second pulse train to a second electrode. The first and second pulse trains are interleaved with one another such that the first and second pulse trains form an activation current density distribution steered to overlay the tissue of interest.

Claims

1. A method for current steering a neurostimulation signal delivered by an implantable pulse generator (IPG) between a plurality of electrodes coupled to the IPG toward tissue of interest, the method comprising:

programming the IPG to deliver at least a first pulse train to a first electrode and a second pulse train to a second electrode, wherein the first and second pulse trains are interleaved with one another such that the first and second pulse trains form an activation current density (ACD) distribution steered to overlay the tissue of interest.

2. The method of claim 1, further comprising programming the IPG to control parameters that define a waveform of at least one of the first and second pulse trains in connection with steering the ACD distribution to overlay the tissue of interest.

3. The method of claim 1, wherein the first pulse train includes first pulses separated by first gaps and the second pulse train includes second pulses separated by second gaps, the first and second pulse trains interleaved in a multiplex manner such that the first pulses temporally align with the second gaps and the second pulses temporally align with the first gaps.

4. The method of claim 1, further comprising programming the IPG to steer the ACD distribution in a select direction by adjusting at least one of an amplitude or a pulse width of the first and second pulse trains.

5. The method of claim 1, wherein the first and second pulse trains define a spinal cord stimulation therapy and the tissue of interest represents a portion of a dorsal column;

the method further comprising programming the IPG to steer the ACD distribution toward the tissue of interest within the dorsal column.

6. The method of claim 1, further comprising programming the IPG to:

deliver pulses of the first pulse train with a first amplitude and pulses of the second pulse train with a second amplitude; and

determine a ratio of the first and second amplitudes to steer the ACD distribution toward the tissue of interest.

7. The method of claim 1, further comprising programming the IPG to:

deliver pulses of the first pulse train with a first pulse width and pulses of the second pulse train with a second pulse width; and

determine a ratio of the first and second pulse widths to steer the ACD distribution toward the tissue of interest.

8. The method of claim 5, wherein the first and second pulse are between one microsecond and fifty microseconds.

9. The method of claim 1, wherein the first and second electrodes are at least one of segmented ring electrodes, electrodes on a paddle structure of the lead, or ring electrodes.

10. The method of claim 1, wherein the first and second pulse trains correspond to a deep brain stimulation therapy.

11. The method of claim 1, further comprising programming the IPG to deliver the first and second pulse trains with the same polarity.

12. The method of claim 1, further comprising programming the IPG to deliver a recharge pulse following at least one of the first or second pulse trains, wherein the recharge pulse has a polarity different than a polarity of the at least one of the first or second pulse trains to provide charge balance.

13. The method of claim 1, wherein the tissue of interest comprises first and second types of cells having first and second chronaxie, respectively, further comprising programming the IPG to determine a length of the first pulse train based on the first chronaxie and a length of the second pulse train based on the second chronaxie.

14. The method of claim 1, further comprising programming the IPG to deliver, within the first pulse train, a first pulse having a positive polarity and a second pulse having a negative polarity to provide charge balance.

15. A system for current steering a neurostimulation signal comprising:

a lead configured to be implanted at a target position proximate to or within a tissue of interest;

a plurality of electrodes on a surface of the lead; and

an implantable pulse generator (IPG) coupled to the lead, the IPG configured to deliver at least a first pulse train to a first electrode and a second pulse train to a second electrode, wherein the first and second pulse trains are interleaved with one another such that the first and second pulse trains form an activation current density (ACD) distribution steered to overlay the tissue of interest.

16. The system of claim 15, wherein the IPG is further configured to control parameters that define a waveform of at least one of the first and second pulse trains in connection with steering the ACD distribution to overlay the tissue of interest.

17. The system of claim 15, wherein the first pulse train includes first pulses separated by first gaps and the second pulse train includes second pulses separated by second gaps, the first and second pulse trains are interleaved in a multiplex manner such that the first pulses temporally align with the second gaps and the second pulses temporally align with the first gaps.

18. The system of claim 15, wherein the IPG is further programmed to steer the ACD distribution in a select direction by adjusting at least one of an amplitude or a pulse width of the first and second pulse trains.

19. The system of claim 15, wherein the first and second pulse trains define a spinal cord stimulation therapy and the tissue of interest represents a portion of a dorsal column, wherein the IPG is further configured to steer the ACD distribution toward the tissue of interest within the dorsal column.

20. The system of claim 15, wherein the first and second pulse trains correspond to a deep brain stimulation therapy.

21. The system of claim 15 wherein one or more of the first electrode and the second electrode comprise segmented ring electrodes and the IPG being further programmed to steer the ACD distribution in a select direction by delivering the first and second pulse trains to selected segments of the first and second electrodes.